Skip to content
8-K

Material Event

SURFACE ONCOLOGY, INC.

0001193125-23-181336

← back to feed
Filed
Jul 3, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted 2022 · Dec 31, 2022 55.76M sh
Shares Diluted 2021 · Dec 31, 2021 44.24M sh
Shares Diluted 2020 · Dec 31, 2020 38.14M sh
Capex 2022 · Dec 31, 2022 $497K
Capex 2021 · Dec 31, 2021 $120K
Capex 2020 · Dec 31, 2020 $43K
Operating Cash Flow 2022 · Dec 31, 2022 −$59.55M
Operating Cash Flow 2021 · Dec 31, 2021 −$62.34M
Operating Cash Flow 2020 · Dec 31, 2020 $30M
Cash And Equivalents 2022 · Dec 31, 2022 $50.91M
Cash And Equivalents 2021 · Dec 31, 2021 $56.05M
Stockholders Equity 2022 · Dec 31, 2022 $93.4M
Stockholders Equity 2021 · Dec 31, 2021 $118.9M
Stockholders Equity 2020 · Dec 31, 2020 $155.75M
Stockholders Equity 2019 · Dec 31, 2019 $56.67M
Current Liabilities 2022 · Dec 31, 2022 $16.26M
Current Liabilities 2021 · Dec 31, 2021 $20.02M
Total Liabilities 2022 · Dec 31, 2022 $66.51M
Total Liabilities 2021 · Dec 31, 2021 $71.95M
Current Assets 2022 · Dec 31, 2022 $129.14M
Current Assets 2021 · Dec 31, 2021 $157.35M
Total Assets 2022 · Dec 31, 2022 $159.91M
Total Assets 2021 · Dec 31, 2021 $190.85M
Eps Diluted 2022 · Dec 31, 2022 −$1.14
Eps Diluted 2021 · Dec 31, 2021 −$1.77
Eps Diluted 2020 · Dec 31, 2020 $1.57
Eps Basic 2022 · Dec 31, 2022 −$1.14
Eps Basic 2021 · Dec 31, 2021 −$1.77
Eps Basic 2020 · Dec 31, 2020 $1.67
Rd Expense 2022 · Dec 31, 2022 $67M
Rd Expense 2021 · Dec 31, 2021 $53.57M
Rd Expense 2020 · Dec 31, 2020 $41.02M
Net Income 2022 · Dec 31, 2022 −$63.59M
Net Income 2021 · Dec 31, 2021 −$78.49M
Net Income 2020 · Dec 31, 2020 $59.34M
Operating Income 2022 · Dec 31, 2022 −$61.87M
Operating Income 2021 · Dec 31, 2021 −$76.01M
Operating Income 2020 · Dec 31, 2020 $61.59M
Revenue 2022 · Dec 31, 2022 $30M
Revenue 2021 · Dec 31, 2021 $2.69M
Revenue 2020 · Dec 31, 2020 $87.57M